A Retrospective Analysis of the Use of Loteprednol Etabonate Ophthalmic Suspension 0.5% Following Canaloplasty
Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s153912
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2018
Authors
Publisher
Informa UK Limited